VFL-53113-42129
4 vaccinations
5 coded responses
34 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 164 / PA
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2020-12-21
Registered in v-safe
- 2020-12-21
- 2020-12-22
- 2020-12-24
- 2020-12-25
- 2020-12-26
-
2021-01-02
Survey response — day 14, dose 1MedDRA: Injection site hypersensitivity — Feeling: GoodFree text: Allergic local reaction at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-12
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-09-29
Dose 3 — Pfizer-BioNTech
- 2021-09-29
-
2021-09-30
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain — Feeling: Good · Site: PainFree text: Pain in left armpitMedDRA releases: 2024-11 · check-in free text available
-
2021-10-01
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain, Oedema peripheral — Feeling: GoodFree text: Left armpit pain/swellingMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain — Feeling: GoodFree text: Left armpit painMedDRA releases: 2024-11 · check-in free text available
- 2021-10-03
- 2021-10-05
- 2021-10-06
- 2021-10-15
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-10
- 2021-12-30
- 2022-03-30
-
2022-09-14
Dose 4 — Moderna
-
2022-10-01
Survey response — 12 months, dose 3MedDRA: Hyperinsulinaemia — Feeling: GoodFree text: HyperunsulinemiaMedDRA releases: 2024-11 · check-in free text available
- 2022-10-05
- 2022-10-12
- 2023-03-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
| 4 | 2022-09-14 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-09 | Unsuccessful |
Free text
Release 1 — day 14, dose 1
Symptoms: Allergic local reaction at injection site
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Pain in left armpit
Systemic reaction (other): Left armpit pain/swelling
Systemic reaction (other): Left armpit pain
Release 12 — 12 months, dose 3
Symptoms: Hyperunsulinemia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hyperinsulinaemia | · | · | ✓ |
| SD | Injection site hypersensitivity | ✓ | ✓ | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release